Calumet Specialty Products Partners (CLMT) Short Interest Ratio & Short Volume → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free CLMT Stock Alerts $16.21 -0.05 (-0.31%) (As of 12:44 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Calumet Specialty Products Partners Short Interest DataCurrent Short Interest1,250,000 sharesPrevious Short Interest1,220,000 sharesChange Vs. Previous Month+2.46%Dollar Volume Sold Short$20.35 millionShort Interest Ratio11.2 Days to CoverLast Record DateMay 31, 2024Outstanding Shares80,390,000 sharesFloat Size64,620,000 sharesShort Percent of Float1.93%Today's Trading Volume11,366 sharesAverage Trading Volume112,222 sharesToday's Volume Vs. Average10% Short Selling Calumet Specialty Products Partners ? Sign up to receive the latest short interest report for Calumet Specialty Products Partners and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLMT Short Interest Over TimeCLMT Days to Cover Over TimeCLMT Percentage of Float Shorted Over Time Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> Calumet Specialty Products Partners Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20241,250,000 shares $20.35 million +2.5%1.9%11.2 $16.28 5/15/20241,220,000 shares $18.75 million +15.1%1.9%9.7 $15.37 4/30/20241,060,000 shares $16.60 million +11.3%1.6%8.8 $15.66 4/15/2024952,600 shares $14.29 million +4.8%1.5%7.6 $15.00 3/31/2024909,000 shares $13.51 million +9.5%1.4%7.4 $14.86 3/15/2024830,500 shares $11.83 million -4.2%1.3%6.8 $14.25 Get the Latest News and Ratings for CLMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calumet Specialty Products Partners and its competitors with MarketBeat's FREE daily newsletter. 2/29/2024866,700 shares $13.47 million +10.4%1.3%7.8 $15.54 2/15/2024785,400 shares $13.67 million -1.9%1.2%7.2 $17.40 1/31/2024800,200 shares $12.22 million +28.6%1.4%7.1 $15.27 1/15/2024622,200 shares $10.64 million +12.2%1.1%4.4 $17.10 12/31/2023554,500 shares $9.91 million +29.4%1.0%4.1 $17.87 12/15/2023428,400 shares $7.27 million -2.6%0.7%3.3 $16.97 11/30/2023439,700 shares $7.57 million +19.7%0.8%3.4 $17.21 11/15/2023367,500 shares $5.38 million +25.7%0.6%2.9 $14.65 10/31/2023292,400 shares $3.81 million +5.3%0.5%2.6 $13.03 10/15/2023277,700 shares $4.75 million -2.0%0.5%3.4 $17.09 9/30/2023283,400 shares $5.41 million +3.3%0.5%3.8 $19.10 9/15/2023274,300 shares $5.35 million -16.2%0.5%3.6 $19.51 8/31/2023327,200 shares $5.74 million -1.2%0.6%4.1 $17.53 8/15/2023331,100 shares $5.28 million +4.1%0.6%3.7 $15.96 7/31/2023318,100 shares $5.20 million -26.8%0.6%3.8 $16.35 7/15/2023434,300 shares $7.16 million +3.2%0.8%5.3 $16.48 6/30/2023420,800 shares $6.67 million +10.7%0.7%5.2 $15.86 6/15/2023380,000 shares $5.91 million +0.8%0.7%4.6 $15.55 5/31/2023377,100 shares $5.92 million -30.8%0.7%4.2 $15.69 5/15/2023544,600 shares $9.08 million +2.7%1.0%6.4 $16.68 4/30/2023530,300 shares $9.19 million +0.6%0.9%5.5 $17.33 4/15/2023527,200 shares $8.68 million +1.8%0.9%5.3 $16.47 3/31/2023517,800 shares $9.00 million +11.7%0.9%5.1 $17.38 3/15/2023463,600 shares $7.76 million +10.5%0.8%3.6 $16.74 2/28/2023419,400 shares $8.18 million -9.0%0.7%2.8 $19.51 2/15/2023461,000 shares $8.57 million -1.7%0.8%3 $18.60 1/31/2023468,800 shares $7.64 million +1.8%0.8%2.9 $16.29 1/15/2023460,400 shares $7.78 million +1.1%0.8%2.7 $16.89 12/30/2022455,200 shares $7.68 million +4.1%0.8%2.4 $16.88 12/15/2022437,100 shares $6.37 million +0.2%0.7%2.3 $14.58 11/30/2022436,100 shares $6.95 million -1.1%0.7%2.6 $15.93 11/15/2022441,000 shares $7.78 million +4.5%0.8%3.1 $17.65 10/31/2022421,900 shares $8.39 million -21.0%0.7%2.6 $19.88 10/15/2022534,100 shares $8.42 million +19.2%0.9%3 $15.76This Weight Loss Company Can't Make Enough Product (Ad)A tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> 9/30/2022448,200 shares $5.74 million +24.3%0.8%2.8 $12.81 9/15/2022360,500 shares $6.00 million -3.7%0.6%2.2 $16.64 8/31/2022374,400 shares $6.48 million -0.6%0.6%2.1 $17.32 8/15/2022376,800 shares $6.13 million -8.6%0.6%2.1 $16.27 7/31/2022412,100 shares $5.07 million -9.8%0.7%2.6 $12.31 7/15/2022456,700 shares $4.80 million +11.6%0.8%3.4 $10.51 6/30/2022409,100 shares $4.25 million -2.9%0.7%3 $10.39 6/15/2022421,400 shares $5.52 million +10.2%0.7%3.2 $13.10 5/31/2022382,500 shares $5.31 million -6.7%0.7%2.9 $13.89 5/15/2022409,900 shares $5.53 million +23.0%0.7%2.6 $13.50 4/30/2022333,200 shares $4.75 million -0.4%0.6%1.8 $14.26 4/15/2022334,400 shares $4.54 million +7.3%0.6%1.8 $13.58 3/31/2022311,600 shares $4.24 million -11.7%0.5%1.5 $13.61 3/15/2022352,900 shares $4.94 million -37.9%0.6%1.6 $13.99 2/28/2022568,300 shares $8.81 million -40.0%1.0%2.5 $15.50 2/15/2022947,600 shares $15.89 million +7.3%1.6%4 $16.77 1/31/2022882,800 shares $12.43 million +23.5%1.5%3.6 $14.08 1/15/2022714,800 shares $11.02 million +0.7%1.2%2.9 $15.42 12/31/2021710,200 shares $9.37 million +7.3%1.2%3 $13.20 12/15/2021661,800 shares $8.90 million +5.2%1.1%2.7 $13.45 11/30/2021629,200 shares $9.30 million +224.8%0.9%2.7 $14.78 11/15/2021193,700 shares $2.71 million +27.4%0.3%0.9 $14.01 10/29/2021152,000 shares $1.67 million -27.1%0.2%0.8 $11.01 10/15/2021208,600 shares $2.19 million +30.2%0.3%1.2 $10.51 9/30/2021160,200 shares $1.27 million +18.6%0.2%1 $7.91 9/15/2021135,100 shares $978,124.00 -28.3%0.2%1 $7.24 8/31/2021188,500 shares $1.30 million +46.4%0.3%1.3 $6.91 8/13/2021128,800 shares $801,136.00 -44.1%0.2%1 $6.22 7/30/2021230,500 shares $1.47 million +141.4%0.4%1.8 $6.37 7/15/202195,500 shares $663,725.00 +12.6%0.2%0.7 $6.95 6/30/202184,800 shares $582,576.00 +26.2%0.1%0.6 $6.87 6/15/202167,200 shares $495,936.00 -10.0%0.1%0.4 $7.38 5/28/202174,700 shares $452,682.00 -52.5%0.1%0.4 $6.06 5/14/2021157,100 shares $864,050.00 +8.6%0.3%0.7 $5.50 4/30/2021144,700 shares $849,389.00 -11.2%0.2%0.7 $5.87 4/15/2021163,000 shares $940,510.00 +43.0%0.3%0.7 $5.77 3/31/2021114,000 shares $671,460.00 +28.4%0.2%0.5 $5.89 3/15/202188,800 shares $440,448.00 +26.7%0.1%0.4 $4.96 2/26/202170,100 shares $279,699.00 +12.3%0.1%0.4 $3.99 2/12/202162,400 shares $250,224.00 -19.6%0.1%0.4 $4.01 1/29/202177,600 shares $253,752.00 +16.7%0.1%0.4 $3.27 1/15/202166,500 shares $207,812.50 -20.7%0.1%0.4 $3.13 12/31/202083,900 shares $260,929.00 -5.1%0.1%0.6 $3.11 12/15/202088,400 shares $338,572.00 -7.1%0.1%0.6 $3.83 11/30/202095,100 shares $344,262.00 -26.9%0.2%0.6 $3.62 11/15/2020130,000 shares $452,400.00 -20.1%0.2%0.8 $3.48 10/30/2020162,700 shares $564,569.00 -23.2%0.3%1 $3.47 10/15/2020211,800 shares $724,356.00 -10.0%0.3%1.4 $3.42 9/30/2020235,200 shares $599,760.00 -15.6%0.4%1.4 $2.55 9/15/2020278,500 shares $710,175.00 -31.8%0.5%1.8 $2.55This Weight Loss Company Can't Make Enough Product (Ad)A tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> 8/31/2020408,200 shares $1.04 million -26.8%0.7%2.8 $2.55 8/14/2020557,300 shares $1.44 million -0.9%0.9%3.6 $2.59 7/31/2020562,300 shares $1.47 million -2.9%0.9%3.2 $2.61 7/15/2020579,200 shares $1.52 million +3.0%0.9%3 $2.63 6/30/2020562,500 shares $1.29 million -15.8%0.9%2.3 $2.30 6/15/2020668,200 shares $1.86 million -13.4%1.1%2.3 $2.79 5/29/2020771,600 shares $1.98 million +21.2%1.2%2.2 $2.57 5/15/2020636,700 shares $1.29 million -17.0%1.0%1.7 $2.03 4/30/2020767,200 shares $1.49 million -11.3%1.2%2.2 $1.94 4/15/2020864,500 shares $1.40 million +20.1%1.4%2.6 $1.62 3/31/2020719,600 shares $1.17 million +16.9%1.2%2.3 $1.62 3/13/2020615,700 shares $1.12 million +4.0%1.0%1.8 $1.82 2/28/2020591,900 shares $651,090.00 +14.5%0.9%2.3 $1.10 2/14/2020517,000 shares $1.21 million -22.0%0.8%2.1 $2.34 1/31/2020663,000 shares $2.47 million -26.1%1.1%2.5 $3.72 1/15/2020896,700 shares $3.79 million +60.7%1.4%3.4 $4.23 12/31/2019558,000 shares $2.62 million -17.6%0.9%2.3 $4.70 8/15/2019529,600 shares $2.13 million +22.2%0.9%2.7 $4.03 CLMT Short Interest - Frequently Asked Questions What is Calumet Specialty Products Partners' current short interest? Short interest is the volume of Calumet Specialty Products Partners shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 1,250,000 shares of CLMT short. 1.93% of Calumet Specialty Products Partners' shares are currently sold short. Learn More on Calumet Specialty Products Partners' current short interest. What is a good short interest ratio for Calumet Specialty Products Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLMT shares currently have a short interest ratio of 11.0. Learn More on Calumet Specialty Products Partners's short interest ratio. Which institutional investors are shorting Calumet Specialty Products Partners? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Calumet Specialty Products Partners: PEAK6 Investments LLC, Fifth Lane Capital LP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Calumet Specialty Products Partners? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.93% of Calumet Specialty Products Partners' floating shares are currently sold short. Is Calumet Specialty Products Partners' short interest increasing or decreasing? Calumet Specialty Products Partners saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 1,250,000 shares, an increase of 2.5% from the previous total of 1,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Calumet Specialty Products Partners' float size? Calumet Specialty Products Partners currently has issued a total of 80,390,000 shares. Some of Calumet Specialty Products Partners' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Calumet Specialty Products Partners currently has a public float of 64,620,000 shares. How does Calumet Specialty Products Partners' short interest compare to its competitors? 1.93% of Calumet Specialty Products Partners' shares are currently sold short. Here is how the short interest of companies compare to Calumet Specialty Products Partners: Sunoco LP (2.82%), CVR Energy, Inc. (6.35%), Delek US Holdings, Inc. (11.99%), Vertex Energy, Inc. (18.92%), BP Prudhoe Bay Royalty Trust (7.62%), Exxon Mobil Co. (1.02%), Chevron Co. (2.83%), ConocoPhillips (1.40%), BP p.l.c. (0.24%), Equinor ASA (0.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Calumet Specialty Products Partners stock? Short selling CLMT is an investing strategy that aims to generate trading profit from Calumet Specialty Products Partners as its price is falling. CLMT shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calumet Specialty Products Partners? A short squeeze for Calumet Specialty Products Partners occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLMT, which in turn drives the price of the stock up even further. How often is Calumet Specialty Products Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLMT, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Sunoco Short Interest CVR Energy Short Interest Delek US Short Interest Vertex Energy Short Interest BP Prudhoe Bay Royalty Trust Short Interest Exxon Mobil Short Interest Chevron Short Interest ConocoPhillips Short Interest BP Short Interest Equinor ASA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLMT) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredAvoid These AI Stocks Like the Plague...Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh co...Weiss Ratings | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calumet Specialty Products Partners, L.P. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calumet Specialty Products Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.